Type |
Details |
Score |
Protein Domain |
Type: |
Family |
Description: |
This entry includes tafazzin and its homologues, such as Taz1 from yeasts and N-acylphosphatidylethanolamine synthase from plants. Tafazzin is an enzyme involved in the cardiolipin remodelling pathway [, ]. The phospholipid cardiolipin is an important component of the inner mitochondrial membrane that is involved in mitochondrial energy production and apoptosis []. In humans tafazzin is expressed at high levels in cardiac and skeletal muscle. As many as 10 isoforms can be present in different amounts in different tissues. Isoforms with hydrophobic N-termini are thought to be membrane anchored, while shorter forms, lacking the hydrophobic stretch, may be cytoplasmic (these latter are found in leukocytes and fibroblasts, but not in heart and skeletal muscle). A central hydrophilic domain may serve as an exposed loop that interacts with other proteins. Defects in the taz gene are the cause of Barth syndrome, a severe inherited disorder, often fatal in childhood. The disease is characterised by cardiac and skeletal myopathy, short stature and neutropenia [].In flies tafazzin is a CoA-independent, acyl-specific phospholipid transacylase with substrate preference for cardiolipin and phosphatidylcholine [].Budding yeast Taz1 is a lyso-phosphatidylcholine acyltransferase that is required for normal phospholipid content of mitochondrial membranes, whose acyl specificity in the reaction relies on lipid chemical composition [, ]. Arabidopsis N-acylphosphatidylethanolamine synthase (NAPE synthase, At1g78690) is an acyltransferase that catalyses the N-acylation of phosphatidylethanolamine to form N-acylphosphatidylethanolamine (N-acyl-PE) []. |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
262
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
zebrafish |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
21
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Schlame M |
Year: |
2017 |
Journal: |
J Biol Chem |
Title: |
The Basis for Acyl Specificity in the Tafazzin Reaction. |
Volume: |
292 |
Issue: |
13 |
Pages: |
5499-5506 |
|
•
•
•
•
•
|
Publication |
First Author: |
Houtkooper RH |
Year: |
2009 |
Journal: |
Biochim Biophys Acta |
Title: |
The enigmatic role of tafazzin in cardiolipin metabolism. |
Volume: |
1788 |
Issue: |
10 |
Pages: |
2003-14 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bione S |
Year: |
1996 |
Journal: |
Nat Genet |
Title: |
A novel X-linked gene, G4.5. is responsible for Barth syndrome. |
Volume: |
12 |
Issue: |
4 |
Pages: |
385-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Testet E |
Year: |
2005 |
Journal: |
Biochem J |
Title: |
Ypr140wp, 'the yeast tafazzin', displays a mitochondrial lysophosphatidylcholine (lyso-PC) acyltransferase activity related to triacylglycerol and mitochondrial lipid synthesis. |
Volume: |
387 |
Issue: |
Pt 3 |
Pages: |
617-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bulat E |
Year: |
2011 |
Journal: |
J Biol Chem |
Title: |
Putative N-acylphosphatidylethanolamine synthase from Arabidopsis thaliana is a lysoglycerophospholipid acyltransferase. |
Volume: |
286 |
Issue: |
39 |
Pages: |
33819-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Malhotra A |
Year: |
2009 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome. |
Volume: |
106 |
Issue: |
7 |
Pages: |
2337-41 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu Y |
Year: |
2006 |
Journal: |
J Biol Chem |
Title: |
The enzymatic function of tafazzin. |
Volume: |
281 |
Issue: |
51 |
Pages: |
39217-24 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
248
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
175
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
238
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
177
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
189
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
64
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
178
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
134
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
263
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
150
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
148
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Acehan D |
Year: |
2009 |
Journal: |
Mitochondrion |
Title: |
Distinct effects of tafazzin deletion in differentiated and undifferentiated mitochondria. |
Volume: |
9 |
Issue: |
2 |
Pages: |
86-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Soustek MS |
Year: |
2011 |
Journal: |
Hum Gene Ther |
Title: |
Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency. |
Volume: |
22 |
Issue: |
7 |
Pages: |
865-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Phoon CK |
Year: |
2012 |
Journal: |
J Am Heart Assoc |
Title: |
Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction. |
Volume: |
1 |
Issue: |
2 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Cole LK |
Year: |
2018 |
Journal: |
Biochim Biophys Acta Mol Basis Dis |
Title: |
Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice. |
Volume: |
1864 |
Issue: |
10 |
Pages: |
3353-3367 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cadalbert LC |
Year: |
2015 |
Journal: |
PLoS One |
Title: |
Mouse Tafazzin Is Required for Male Germ Cell Meiosis and Spermatogenesis. |
Volume: |
10 |
Issue: |
6 |
Pages: |
e0131066 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim J |
Year: |
2018 |
Journal: |
Mitochondrion |
Title: |
Cardiac mitochondrial structure and function in tafazzin-knockdown mice. |
Volume: |
43 |
|
Pages: |
53-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hsu P |
Year: |
2015 |
Journal: |
Autophagy |
Title: |
Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy. |
Volume: |
11 |
Issue: |
4 |
Pages: |
643-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Acehan D |
Year: |
2011 |
Journal: |
J Biol Chem |
Title: |
Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. |
Volume: |
286 |
Issue: |
2 |
Pages: |
899-908 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maguire ARR |
Year: |
2021 |
Journal: |
Immunohorizons |
Title: |
Tafazzin Modulates Allergen-Induced Mast Cell Inflammatory Mediator Secretion. |
Volume: |
5 |
Issue: |
4 |
Pages: |
182-192 |
|
•
•
•
•
•
|
Publication |
First Author: |
Le CH |
Year: |
2020 |
Journal: |
J Biol Chem |
Title: |
Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria. |
Volume: |
295 |
Issue: |
35 |
Pages: |
12485-12497 |
|
•
•
•
•
•
|
UniProt Feature |
Begin: |
1 |
Description: |
Tafazzin |
Type: |
chain |
End: |
262 |
|
•
•
•
•
•
|
Publication |
First Author: |
Powers C |
Year: |
2013 |
Journal: |
Front Physiol |
Title: |
Diminished Exercise Capacity and Mitochondrial bc1 Complex Deficiency in Tafazzin-Knockdown Mice. |
Volume: |
4 |
|
Pages: |
74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kimura T |
Year: |
2018 |
Journal: |
Biochemistry |
Title: |
Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency. |
Volume: |
57 |
Issue: |
14 |
Pages: |
2162-2175 |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Publication |
First Author: |
Cole LK |
Year: |
2021 |
Journal: |
Endocrinology |
Title: |
Tafazzin Deficiency Reduces Basal Insulin Secretion and Mitochondrial Function in Pancreatic Islets From Male Mice. |
Volume: |
162 |
Issue: |
7 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Zegallai HM |
Year: |
2022 |
Journal: |
FASEB J |
Title: |
Tafazzin deficiency in mouse mesenchymal stem cells promote reprogramming of activated B lymphocytes toward immunosuppressive phenotypes. |
Volume: |
36 |
Issue: |
8 |
Pages: |
e22443 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang S |
Year: |
2023 |
Journal: |
Hum Mol Genet |
Title: |
Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome. |
Volume: |
32 |
Issue: |
12 |
Pages: |
2055-2067 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zegallai HM |
Year: |
2021 |
Journal: |
FASEB J |
Title: |
Tafazzin deficiency impairs mitochondrial metabolism and function of lipopolysaccharide activated B lymphocytes in mice. |
Volume: |
35 |
Issue: |
12 |
Pages: |
e22023 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sohn J |
Year: |
2022 |
Journal: |
Blood Adv |
Title: |
A new murine model of Barth syndrome neutropenia links TAFAZZIN deficiency to increased ER stress-induced apoptosis. |
Volume: |
6 |
Issue: |
8 |
Pages: |
2557-2577 |
|
•
•
•
•
•
|
Publication |
First Author: |
Szczepanek K |
Year: |
2016 |
Journal: |
Biochim Biophys Acta |
Title: |
Acquired deficiency of tafazzin in the adult heart: Impact on mitochondrial function and response to cardiac injury. |
Volume: |
1861 |
Issue: |
4 |
Pages: |
294-300 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ren M |
Year: |
2019 |
Journal: |
Am J Physiol Heart Circ Physiol |
Title: |
A critical appraisal of the tafazzin knockdown mouse model of Barth syndrome: what have we learned about pathogenesis and potential treatments? |
Volume: |
317 |
Issue: |
6 |
Pages: |
H1183-H1193 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhu S |
Year: |
2022 |
Journal: |
Circulation |
Title: |
Mitochondrial Stress Induces an HRI-eIF2α Pathway Protective for Cardiomyopathy. |
Volume: |
146 |
Issue: |
13 |
Pages: |
1028-1031 |
|
•
•
•
•
•
|
Publication |
First Author: |
Seneviratne AK |
Year: |
2019 |
Journal: |
Cell Stem Cell |
Title: |
The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of Phospholipids. |
Volume: |
24 |
Issue: |
4 |
Pages: |
621-636.e16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chowdhury A |
Year: |
2018 |
Journal: |
Cell Rep |
Title: |
Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia. |
Volume: |
25 |
Issue: |
3 |
Pages: |
561-570.e6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Goncalves RLS |
Year: |
2020 |
Journal: |
FEBS Lett |
Title: |
Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide/H2 O2 production in heart and skeletal muscle mitochondria. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ikon N |
Year: |
2018 |
Journal: |
J Biomed Res |
Title: |
Evaluation of cardiolipin nanodisks as lipid replacement therapy for Barth syndrome |
Volume: |
32 |
Issue: |
2 |
Pages: |
107-112 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang S |
Year: |
2020 |
Journal: |
Circ Res |
Title: |
AAV Gene Therapy Prevents and Reverses Heart Failure in a Murine Knockout Model of Barth Syndrome. |
Volume: |
126 |
Issue: |
8 |
Pages: |
1024-1039 |
|
•
•
•
•
•
|
Publication |
First Author: |
Braun JL |
Year: |
2019 |
Journal: |
Physiol Rep |
Title: |
SERCA2a tyrosine nitration coincides with impairments in maximal SERCA activity in left ventricles from tafazzin-deficient mice. |
Volume: |
7 |
Issue: |
16 |
Pages: |
e14215 |
|
•
•
•
•
•
|
Publication |
First Author: |
Johnson JM |
Year: |
2018 |
Journal: |
J Mol Cell Cardiol |
Title: |
Targeted overexpression of catalase to mitochondria does not prevent cardioskeletal myopathy in Barth syndrome. |
Volume: |
121 |
|
Pages: |
94-102 |
|
•
•
•
•
•
|
Publication |
First Author: |
Suzuki-Hatano S |
Year: |
2019 |
Journal: |
Mol Ther Methods Clin Dev |
Title: |
AAV9-TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome. |
Volume: |
13 |
|
Pages: |
167-179 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kimura T |
Year: |
2019 |
Journal: |
Life Sci Alliance |
Title: |
Plasmalogen loss caused by remodeling deficiency in mitochondria. |
Volume: |
2 |
Issue: |
4 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Kiebish MA |
Year: |
2013 |
Journal: |
J Lipid Res |
Title: |
Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome. |
Volume: |
54 |
Issue: |
5 |
Pages: |
1312-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Soustek MS |
Year: |
2015 |
Journal: |
J Inherit Metab Dis |
Title: |
Endurance training ameliorates complex 3 deficiency in a mouse model of Barth syndrome. |
Volume: |
38 |
Issue: |
5 |
Pages: |
915-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Y |
Year: |
2019 |
Journal: |
J Biol Chem |
Title: |
Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function. |
Volume: |
294 |
Issue: |
30 |
Pages: |
11568-11578 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhu S |
Year: |
2021 |
Journal: |
Circ Heart Fail |
Title: |
Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy. |
Volume: |
14 |
Issue: |
6 |
Pages: |
e008289 |
|
•
•
•
•
•
|
Publication |
First Author: |
Suzuki-Hatano S |
Year: |
2019 |
Journal: |
Hum Gene Ther |
Title: |
AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome. |
Volume: |
30 |
Issue: |
2 |
Pages: |
139-154 |
|
•
•
•
•
•
|
Publication |
First Author: |
Corrado M |
Year: |
2020 |
Journal: |
Cell Metab |
Title: |
Dynamic Cardiolipin Synthesis Is Required for CD8+ T Cell Immunity. |
Volume: |
32 |
Issue: |
6 |
Pages: |
981-995.e7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cole LK |
Year: |
2020 |
Journal: |
J Mol Cell Cardiol |
Title: |
Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy. |
Volume: |
144 |
|
Pages: |
24-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bertero E |
Year: |
2021 |
Journal: |
Circulation |
Title: |
Loss of Mitochondrial Ca2+ Uniporter Limits Inotropic Reserve and Provides Trigger and Substrate for Arrhythmias in Barth Syndrome Cardiomyopathy. |
Volume: |
144 |
Issue: |
21 |
Pages: |
1694-1713 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lu B |
Year: |
2004 |
Journal: |
Biochem Cell Biol |
Title: |
Complex expression pattern of the Barth syndrome gene product tafazzin in human cell lines and murine tissues. |
Volume: |
82 |
Issue: |
5 |
Pages: |
569-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ostojic O |
Year: |
2013 |
Journal: |
J Appl Physiol (1985) |
Title: |
The effects of chronic muscle use and disuse on cardiolipin metabolism. |
Volume: |
114 |
Issue: |
4 |
Pages: |
444-52 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus pahari |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus spretus |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7620338 |
Assay Type: |
RT-PCR |
Annotation Date: |
2024-04-12 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1610528 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7620353 |
Age: |
postnatal day 10 |
|
|
Specimen Label: |
Ctrl |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7620338 |
Assay Type: |
RT-PCR |
Annotation Date: |
2024-04-12 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1610528 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7620353 |
Age: |
postnatal day 10 |
|
|
Specimen Label: |
cKO |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7620338 |
Assay Type: |
RT-PCR |
Annotation Date: |
2024-04-12 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1610528 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7620353 |
Age: |
postnatal day 10 |
|
|
Specimen Label: |
TKO |
Detected: |
false |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7620338 |
Assay Type: |
RT-PCR |
Annotation Date: |
2024-04-12 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1610528 |
|
Stage: |
TS28 |
Assay Id: |
MGI:7620353 |
Age: |
postnatal day 10 |
|
|
Specimen Label: |
dcKO |
Detected: |
false |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5309817 |
Assay Type: |
RNA in situ |
Annotation Date: |
2012-06-12 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:3516422 |
|
Stage: |
TS22 |
Assay Id: |
MGI:5423143 |
Age: |
embryonic day 14.5 |
|
|
Specimen Label: |
EB28; Specimen B152 |
Detected: |
false |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5309817 |
Assay Type: |
RNA in situ |
Annotation Date: |
2012-06-12 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1716122 |
|
Stage: |
TS22 |
Assay Id: |
MGI:5423143 |
Age: |
embryonic day 14.5 |
|
|
Specimen Label: |
EB28; Specimen B152 |
Detected: |
false |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5309817 |
Assay Type: |
RNA in situ |
Annotation Date: |
2012-06-12 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1691622 |
|
Stage: |
TS22 |
Assay Id: |
MGI:5423143 |
Age: |
embryonic day 14.5 |
|
|
Specimen Label: |
EB28; Specimen B152 |
Detected: |
false |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5309817 |
Assay Type: |
RNA in situ |
Annotation Date: |
2012-06-12 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1760622 |
|
Stage: |
TS22 |
Assay Id: |
MGI:5423143 |
Age: |
embryonic day 14.5 |
|
|
Specimen Label: |
EB28; Specimen B152 |
Detected: |
false |
Specimen Num: |
1 |
|
•
•
•
•
•
|